BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 35647690)

  • 1. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
    Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
    Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
    Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver.
    Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y
    Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.
    Luo J; Luo M; Kaminga AC; Wei J; Dai W; Peng Y; Zhao K; Duan Y; Xiao X; Ouyang S; Yao Z; Liu Y; Pan X
    Microbiol Spectr; 2024 Apr; 12(4):e0523022. PubMed ID: 38445874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tian G; Wang W; Xia E; Chen W; Zhang S
    Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Abdollahiyan S; Nabavi-Rad A; Keshavarz Azizi Raftar S; Monnoye M; Salarieh N; Farahanie A; Asadzadeh Aghdaei H; Zali MR; Hatami B; Gérard P; Yadegar A
    Sci Rep; 2023 Nov; 13(1):20584. PubMed ID: 37996480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
    Hamid H; Zhang JY; Li WX; Liu C; Li ML; Zhao LH; Ji C; Ma QG
    Poult Sci; 2019 Jun; 98(6):2509-2521. PubMed ID: 30690636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis.
    Gómez-Pérez AM; Ruiz-Limón P; Salas-Salvadó J; Vioque J; Corella D; Fitó M; Vidal J; Atzeni A; Torres-Collado L; Álvarez-Sala A; Martínez MÁ; Goday A; Benaiges D; García-Gavilán J; Bernal López MR; Moreno-Indias I; Tinahones FJ
    Gut Microbes; 2023; 15(1):2223339. PubMed ID: 37345236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
    Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
    Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li T; Lin X; Shen B; Zhang W; Liu Y; Liu H; Wang Y; Zheng L; Zhi F
    Front Immunol; 2022; 13():1047570. PubMed ID: 36531991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice
    Yan J; Nie Y; Liu Y; Li J; Wu L; Chen Z; He B
    Front Cell Infect Microbiol; 2022; 12():824597. PubMed ID: 35531334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.